Cargando…
Treating Inflammation Associated with Pulmonary Hypertension: An Overview of the Literature
Pulmonary hypertension (PH) comprises five groups of serious clinical entities characterized by pulmonary artery vasoconstriction and vascular remodeling leading to right heart failure and death. In addition to vascular remodeling, recruitment and exaggerated accumulation of several perivascular inf...
Autores principales: | Yoo, Hugo Hyung Bok, Marin, Flávia Luiza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820454/ https://www.ncbi.nlm.nih.gov/pubmed/35140509 http://dx.doi.org/10.2147/IJGM.S295463 |
Ejemplares similares
-
Overview of current therapeutic approaches for pulmonary hypertension
por: Stamm, Jason A., et al.
Publicado: (2011) -
Perivascular Inflammation in Pulmonary Arterial Hypertension
por: Hu, Yijie, et al.
Publicado: (2020) -
Overview of Riociguat and Its Role in the Treatment of Pulmonary Hypertension
por: Kenny, Marianne, et al.
Publicado: (2020) -
Circulating Plasma miRNA and Clinical/Hemodynamic Characteristics Provide Additional Predictive Information About Acute Pulmonary Thromboembolism, Chronic Thromboembolic Pulmonary Hypertension and Idiopathic Pulmonary Hypertension
por: Fabro, Alexandre Todorovic, et al.
Publicado: (2021) -
An Overview of miRNAs Involved in PASMC Phenotypic Switching in Pulmonary Hypertension
por: Zhang, Weifang, et al.
Publicado: (2021)